Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCH 900518 in Previously Untreated Genotype 1 Chronic Hepatitis C
NCT00797745Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of narlaprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started Nov 2008; status: completed.
02
Drugs
narlaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00797745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797745.